Third generation anticonvulsants in bipolar disorder: A review of efficacy and summary of clinical recommendations

Journal of Clinical Psychiatry

Volumn 63, Issue 4, 2002, Pages 275-283

  Yatham, Lakshmi N ^a   Kusumakar, Vivek ^a   Calabrese, Joseph R ^a   Rao, Rajeev ^a   Scarrow, Gayle ^a   Kroeker, Garth ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; OLANZAPINE; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; ZONISAMIDE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEADACHE; HUMAN; LONG TERM CARE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PROPHYLAXIS; RASH; SOMNOLENCE; VERTIGO; VISUAL DISORDER;

EID: 0036238952     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n0402     Document Type: Article

References (97)

1. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study
2. The co-occurrence of mania with medical and other psychiatric disorders
3. Mortality during initial and during later lithium treatment: A collaborative study by the International Group for the Study of Lithium-Treated Patients
4. Cardiovascular risk factors in affective disorder
5. Das manisch-depressive Irresein
6. Efficacy of divalproex vs lithium and placebo in the treatment of mania
7. Depression during mania: Treatment response to lithium or divalproex
8. Carbamazepine and valproate monotherapy: Feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder
9. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study
10. Carbamazepine compared with lithium in the treatment of mania
11. Carbamazepine vs lithium in the treatment and prophylaxis of mania
12. Use of carbamazepine in acute psychosis: A controlled study
13. Carbamazepine versus lithium in mania: A double-blind study
14. Bipolar depression: Treatment options
15. Treatment of acute bipolar depression: A review of the literature
16. Lithium and anticonvulsants in bipolar disorder
17. Lithium carbonate and affective disorders, 5: A double-blind study of prophylaxis of depression in bipolar illness
18. Maintenance therapies in bipolar disorder
19. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder
20. Bipolar rapid cycling: Focus on depression as its hallmark
21. Safety and efficacy of risperidone as combination therapy for the manic phase of bipolar disorder: Preliminary findings of a randomized double blind study (RIS-INT-46)
22. Safety and efficacy of risperidone versus placebo in combination with lithium or valproate in the treatment of the manic phase of the bipolar disorder
23. Olanzapine versus placebo in the treatment of acute mania
24. Efficacy of olanzapine combined with mood stabilizers in the treatment of bipolar disorder
25. Use of lamotrigine in the treatment of bipolar disorder
26. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder
27. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar affective disorder
28. Lamotrigine and gabapentin: Alternative in the treatment of bipolar disorder
29. Lamotrigine treatment of refractory bipolar disorder
30. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness
31. An open study of lamotrigine in refractory bipolar depression
32. Lamotrigine treatment of rapid cycling bipolar disorder
33. Lamotrigine/valproate in treatment resistant bipolar disorder in children and adolescents
34. Lamotrigine in rapid-cycling bipolar disorder
35. Lamotrigine for treatment-refractory bipolar disorder
36. Lamotrigine in the treatment of resistant bipolar disorder
37. New perspectives in the treatment of acute mania: A single case report
38. Lamotrigine in the treatment of schizoaffective disorder
39. Lamotrigine for the treatment of bipolar disorder: A clinical case series
40. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder
41. The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder
42. Lamotrigine as prophylaxis against steroid-induced mania
43. Lamotrigine in the treatment of bipolar depression and other affective disorders: Clinical experience in 218 patients
44. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression
45. A one year continuation study of lamotrigine treatment in bipolar depression
46. A one-year open-label study of the safety and efficacy of lamotrigine in the treatment of bipolar depression
47. Lamotrigine and the treatment of mania in bipolar disorder
48. Lamotrigine treatment of lithium failure outpatient mania: A double blind placebo controlled trial
49. Spectrum of efficacy of lamotrigine in bipolar disorder: Overview of double blind placebo controlled studies
50. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia
51. Lamotrigine demonstrates long term mood stabilization in recently manic patients
52. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder
53. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
54. Gabapentin in the treatment of bipolar disorder
55. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder
56. Gabapentin: An effective therapy for patients with bipolar affective disorder
57. Gabapentin in bipolar disorder
58. Acute treatment of bipolar depression with gabapentin
59. Gabapentin for treatment of bipolar and schizoaffective disorders
60. Treatment of acute mania with gabapentin
61. Gabapentin in the treatment of adolescent mania: A case report
62. Gabapentin treatment of mood disorders: A preliminary study
63. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania
64. Gabapentin in geriatric psychiatry patients
65. An open label study of gabapentin in the treatment of acute mania
66. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment
67. Gabapentin as an adjunctive treatment in bipolar disorder
68. Gabapentin in the treatment of bipolar disorders
69. Gabapentin in the acute treatment of refractory bipolar disorder
70. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states
71. Clinical experience with gabapentin in patients with bipolar or schizoaffective disorder: Results of an open-label study
72. Gabapentin as monotherapy in the treatment of acute mania
73. Gabapentin in bipolar depression
74. Gabapentin in bipolar disorder: A placebo controlled trial of adjunctive therapy
75. Topiramate in severe treatment refractory mania
76. Use of topiramate, a new anti-epileptic as a mood stabilizer
77. Mood stabilization and weight loss with topiramate
78. Treatment of acute mania with topiramate
79. Topiramate as add-on treatment for patients with bipolar mania
80. Open-label adjunctive topiramate in the treatment of bipolar disorders
81. Topiramate in women with refractory rapid cycling bipolar disorder
82. Treatment of bipolar depression with topiramate
83. Topiramate in the treatment of refractoy bipolar disorder
84. Topiramate demonstrates anti-manic efficacy in an open trial with an on-off-on design
85. Topiramate in the adjunctive treatment of refractory bipolar disorder
86. Topiramate shows efficacy in the treatment of refractory bipolar mood disorder
87. Effects of topiramate on global functioning in treatment refractory mood disorders
88. Topiramate in bipolar and schizoaffective disorder: Mood stabilizing properties in treatment refractory patients
89. Topiramate versus placebo in mania
90. Tiagabine and the treatment of refractory bipolar disorder
91. Adjunctive tiagabine treatment of psychiatric disorders: Three cases
92. Tiagabine appears not to be efficacious in the treatment of acute mania
93. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania
94. Safety review of adult clinical trial experience with lamotrigine
95. Factors influencing the incidence of lamotrigine-related skin rash
96. Placebo-controlled study of gabapentin treatment of panic disorder
97. Treatment of social phobia with gabapentin: A placebo-controlled study